BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/20/2021 2:13:53 AM | Browse: 814 | Download: 2427
 |
Received |
|
2020-12-12 00:57 |
|
Peer-Review Started |
|
2020-12-12 00:59 |
|
First Decision by Editorial Office Director |
|
2021-01-07 07:07 |
|
Return for Revision |
|
2021-01-07 07:07 |
|
Revised |
|
2021-01-15 18:25 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-02-23 06:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-03-09 03:38 |
|
Articles in Press |
|
2021-03-09 03:38 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-18 02:28 |
|
Publish the Manuscript Online |
|
2021-03-20 02:13 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chrystelle L Vilfranc, Li-Xiao Che, Krushna C Patra, Liang Niu, Olugbenga Olowokure, Jiang Wang, Shimul A Shah and Chun-Ying Du |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| NIH 1 (Du CY) |
R21CA241025-01 |
| NIH (Du CY) |
RO1CA158323 |
| NCI RO1 Diversity Supplement (Du CY) |
R01CA158323-05S |
| National Center for Advancing Translational Sciences of the National Institutes of Health (Du CY) |
2UL1TR001425-05A1 |
| University of Cincinnati Center for Environmental Genetics-NIH/NIEHS award (Du CY) |
P30 ES006096 |
| Pathways to Cancer Therapeutics T32 (Du CY and Vilfranc CL) |
CA117846-12 |
|
| Corresponding Author |
Chun-Ying Du, PhD, Associate Professor, Department of Cancer Biology, University of Cincinnati, 3125 Eden Avenue Room # 3216, Cincinnati, OH 45267, United States. ducg@ucmail.uc.edu |
| Key Words |
Baculovirus repeat-containing ubiquitin conjugating enzyme; Diethylnitrosamine; Mouse model; Liver fibrosis; Liver cancer; Hepatocellular carcinoma |
| Core Tip |
Upon diethylnitrosamine (DEN) exposure, baculovirus repeat-containing ubiquitin conjugating enzyme (BRUCE) liver-deficiency accelerates chronic liver diseases such as fibrosis and hepatocellular carcinoma (HCC) in mice. Our previous study established the role of BRUCE in the protection of the liver against DEN-induced liver injury and subsequent disease progression. Here we report a chronic fibrosis background induced by hepatic BRUCE knockout in mice that recapitulates the fibrosis background in HCC patients. We also report a BRUCE-dependent suppression of β-catenin activity through the suppression of protein kinase A (PKA) activity. This study provides a therapeutic potential involving the inhibition of PKA and β-catenin activities in patients with liver disease that carry BRUCE inactivating mutations resulting in BRUCE-deficiency. |
| Publish Date |
2021-03-20 02:13 |
| Citation |
Vilfranc CL, Che LX, Patra KC, Niu L, Olowokure O, Wang J, Shah SA, Du CY. BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis. World J Hepatol 2021; 13(3): 343-361 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i3/343.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i3.343 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
